Literature DB >> 8367826

Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy.

M Feldkamp1, J C Carey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8367826     DOI： 10.1002/tera.1420470605

Source DB:  PubMed          Journal:  Teratology        ISSN： 0040-3709


× No keyword cloud information.
  20 in total

1.  Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy.

Authors:  Sonia Panchal; Manjiri Khare; Arumugam Moorthy; Ash Samanta
Journal:  Rheumatol Int       Date:  2012-03-27       Impact factor: 2.631

Review 2.  Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future.

Authors:  Fokaline Vroom; Hermien E K de Walle; Mart A J F van de Laar; Jacobus R B J Brouwers; Lolkje T W de Jong-van den Berg
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Identifying Human Teratogens: An Update.

Authors:  Sura Alwan; Christina D Chambers
Journal:  J Pediatr Genet       Date:  2015-06

4.  Maternal autoimmune disease and birth defects in the National Birth Defects Prevention Study.

Authors:  Meredith M Howley; Marilyn L Browne; Alissa R Van Zutphen; Sandra D Richardson; Sarah J Blossom; Cheryl S Broussard; Suzan L Carmichael; Charlotte M Druschel
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

5.  [Systemic drug treatment during pregnancy].

Authors:  Maximilian Riedel; Bettina Kuschel
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

Review 6.  The management of rheumatic diseases in pregnancy.

Authors:  K Mitchell; M Kaul; Megan E B Clowse
Journal:  Scand J Rheumatol       Date:  2010-03       Impact factor: 3.641

Review 7.  Effect of methotrexate treatment of ectopic pregnancy on subsequent pregnancy.

Authors:  Rinat Hackmon; Sachi Sakaguchi; Gideon Koren
Journal:  Can Fam Physician       Date:  2011-01       Impact factor: 3.275

Review 8.  [Antirheumatic therapy and reproduction. The influence on fertility, pregnancy and breast feeding].

Authors:  M Ostensen
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

9.  Maternal exposure to methotrexate and birth defects: a population-based study.

Authors:  April L Dawson; Tiffany Riehle-Colarusso; Jennita Reefhuis; J Fernando Arena
Journal:  Am J Med Genet A       Date:  2014-06-04       Impact factor: 2.802

Review 10.  Management of RA medications in pregnant patients.

Authors:  Monika Østensen; Frauke Förger
Journal:  Nat Rev Rheumatol       Date:  2009-06-09       Impact factor: 20.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.